SBI Securities »

Rani Therapeutics Hldgs shares owned by SBI Securities

Quarter-by-quarter ownership of Rani Therapeutics Hldgs (RANI) shares owned by SBI Securities from 13F filings

Historical chart of SBI Securities investment in Rani Therapeutics Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Rani Therapeutics Hldgs held by SBI Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rani Therapeutics Hldgs by SBI Securities

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.3k 13k 0.50
2025-06-30 $4.9k 9.6k 0.51
2025-03-31 $9.7k 7.7k 1.26
2024-12-31 $9.7k 7.1k 1.37

More positions owned by SBI Securities

NVIDIA Corporation (NVDA)
Vanguard S&P 500 ETF Etf (VOO)
Vanguard Total Stock Market ETF Etf (VTI)
Tesla Motors (TSLA)
Apple (AAPL)
Invesco QQQ Trust Series 1 ETF Etf (QQQ)
Palantir Technologies (PLTR)
Microsoft Corporation (MSFT)
Vanguard Total World Stock ETF Etf (VT)
Amazon (AMZN)
Vanguard High Dividend Yield ETF Etf (VYM)
Alphabet Inc Class A cs (GOOGL)
SPDR Portfolio S&P500 HighDividend ETF Etf (SPYD)
Facebook Inc cl a (META)
Direxion Daily Semi Bull 3X Etf (SOXL)

View all positions for SBI Securities

Top funds holding Rani Therapeutics Hldgs

Vanguard Group
Nan Fung Group Holdings
Citadel Advisors
United Services Automobile Association
Geode Capital Management
Kestra Private Wealth Services
Takeda Pharmaceutical
CWA Asset Management
BlackRock
Hrt Financial
Northern Trust
UBS Group
Marc Lasry
State Street Corporation
Luther King Capital Management Corporation

View all funds holding Rani Therapeutics Hldgs